Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06588205
- Locations
- 🇮🇹
U.O.C. Ematologia - A.O.U. Senese, Siena, Italy
🇮🇹A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia, Ancona, Italy
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
- Conditions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 400
- Registration Number
- NCT06588868
- Locations
- 🇮🇹
U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale, Bari, Italy
🇮🇹Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
🇮🇹S.C. Dermatologia - E.O. Galliera, Genova, Italy
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
- Conditions
- Interventions
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 56
- Registration Number
- NCT06492837
- Locations
- 🇮🇹
ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia, Milano, Italy
🇮🇹IRCCS Istituto Tumori Giovanni Paolo II, U.O.C Ematologia, Bari, Italy
🇮🇹A.O.U. Città della Salute e della Scienza di Torino, S.C.Ematologia, Torino, Italy
Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 125
- Registration Number
- NCT06441214
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, Firenze, Italy
🇮🇹A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹A.O.U. Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
PTLD: Multicentric Retrospective Study
- Conditions
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06422715
- Locations
- 🇮🇹
Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati, Aviano, Italy
🇮🇹A.O. Spedali Civili di Brescia - Ematologia, Brescia, Italy
🇮🇹Istituto Scientifico San Raffaele - Unitа Linfomi - Dipartimento Oncoematologia, Milano, Italy
SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
- Conditions
- Interventions
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 130
- Registration Number
- NCT06156774
- Locations
- 🇮🇹
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
🇮🇹Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
- Conditions
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 150
- Registration Number
- NCT06113081
- Locations
- 🇮🇹
S.C. Ematologia e CTMO - A.O. Brotzu Ospedale Businco, Cagliari, Italy
🇮🇹S.C. Ematologia e Terapie Cellulari - IRCCS Policlinico S. Martino, Genova, Italy
🇮🇹U.O.C. Dermatologia . A.O.U. di Padova, Padova, Italy
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
- Conditions
- Interventions
- Diagnostic Test: Cellular immunity vs SARS-CoV-2Diagnostic Test: Humoral immunity vs SARS-CoV-2Diagnostic Test: Cellular immunity vs Varicella Zoster VirusDiagnostic Test: Humoral immunity vs Varicella Zoster VirusDiagnostic Test: Diphtheria toxin-binding IgGDiagnostic Test: Tetanus toxoid-binding IgGDiagnostic Test: T-cell populations and markers characterization
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 56
- Registration Number
- NCT06070961
- Locations
- 🇮🇹
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia, Alessandria, IT, Italy
🇮🇹Nuovo Ospedale degli Infermi, SSD Ematologia, Biella, IT, Italy
🇮🇹ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia, Milano, IT, Italy
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
- Conditions
- Interventions
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 1500
- Registration Number
- NCT06008691
- Locations
- 🇮🇹
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
🇮🇹IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati, Aviano, Italy
🇮🇹IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, Italy
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 28
- Registration Number
- NCT05977673
- Locations
- 🇮🇹
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia, Alessandria, IT, Italy
🇮🇹Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano, Aviano, Italy
🇮🇹Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi, Bologna, Italy